These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1511608)

  • 21. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
    Somell C; Olund A; Kindahl H; Larsson B
    Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. World Health Organization. Task Force on Post-ovulatory Methods for Fertility Regulation.
    Br J Obstet Gynaecol; 1990 Mar; 97(3):260-6. PubMed ID: 2185822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
    Carbonne B; Brennand JE; Maria B; Cabrol D; Calder AA
    Br J Obstet Gynaecol; 1995 Jul; 102(7):553-8. PubMed ID: 7647058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical ripening with mifepristone (RU 486) in late first trimester abortion. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation.
    Contraception; 1994 Nov; 50(5):461-75. PubMed ID: 7859455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of RU-38486 on cervical ripening. Clinical studies.
    Lefebvre Y; Proulx L; Elie R; Poulin O; Lanza E
    Am J Obstet Gynecol; 1990 Jan; 162(1):61-5. PubMed ID: 2301519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the progesterone antagonist, RU 486 (mifepristone), in preoperative cervical dilatation during the luteal phase. A randomized double-blind study].
    Fernandez H; Durlot F; Dubois C; Ulmann A; Frydman R
    Contracept Fertil Sex (Paris); 1990 Jan; 18(1):41-3. PubMed ID: 12283016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone does not induce cervical softening in non-pregnant women.
    Ben-Chetrit A; Eldar-Geva T; Lindenberg T; Farhat M; Shimonovitz S; Zacut D; Gelber H; Sitruk-Ware R; Spitz IM
    Hum Reprod; 2004 Oct; 19(10):2372-6. PubMed ID: 15271871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in adrenergic receptors in the pregnant human uterine cervix following mifepristone or placebo treatment in the first trimester.
    Kovács L; Falkay G
    Hum Reprod; 1993 Jan; 8(1):119-21. PubMed ID: 8458913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
    Ngai SW; Yeung KC; Lao T; Ho PC
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1120-3. PubMed ID: 8917000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of a new vaginal suppository: prostaglandin E1 analog Gemeprost for cervix maturation prior to abortion in the 1st trimester].
    Rabe T; Helk J; Kiesel L; Zwick J; Runnebaum B
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):393-401. PubMed ID: 3894147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could antiprogesterones be used as alternative cervical ripening agents?
    Johnson N; Bryce FC
    Am J Obstet Gynecol; 1990 Mar; 162(3):688-90. PubMed ID: 2316569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
    Gemzell-Danielsson K; Hamberg M
    Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix.
    Denison FC; Riley SC; Elliott CL; Kelly RW; Calder AA; Critchley HO
    Mol Hum Reprod; 2000 Jun; 6(6):541-8. PubMed ID: 10825372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histological study of uterine cervix during termination of early pregnancy by mifepristone and prostaglandins].
    Weng L; Jiao L; Tang X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):522-5. PubMed ID: 8556909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.
    Bygdeman M; Gemzell K; Gottlieb C; Swahn ML
    Ann N Y Acad Sci; 1991; 626():561-7. PubMed ID: 2058973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
    Pons JC; Rais S; Diochin P; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):255-7. PubMed ID: 1583307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.